Latest News

Research group led by Heidelberg University Hospital identified enzyme that modifies motor proteins of heart muscle cells and thus influences their function / Results published in Nature Communications

If everything goes optimally, the new heart centre at Heidelberg University Hospital could go into operation as early as 2029. The state of Baden-Württemberg supports the construction project and, on Tuesday, October 25, declared its support for the importance of the planned new...

An overactive enzyme that causes an inherited form of high blood pressure also appears to protect against hypertension-induced cardiac damage. A team of researchers from the Max Delbrück Center, ECRC, and DZHK led by Enno Klußmann explains in the journal Circulation how this...

Prof. Dr. Wolfgang Hoffmann from the Greifswald University Hospital was elected as the new chairman of the DNVF at the beginning of October. He will thus head the ten-member board of the German Network for Health Services Research (DNVF) for the next two years. Hoffmann has been...

At the University Medical Center Schleswig-Holstein, Campus Kiel, Prof. Dr. Derk Frank has been the new director of the Clinic for Internal Medicine III, focusing on cardiology, angiology and internal intensive care medicine since October 1. Previously, he was the acting director...

Dilated cardiomyopathy, a heart muscle disease, is the most common cause of heart transplants. Dr. Julian Grünewald from the Technical University of Munich (TUM) wants to treat a particularly aggressive form of this disease by intervening in the genome. To do this, he uses a...

The NOAH – AFNET 6 trial which is conducted to evaluate the potential benefit of oral anticoagulation in patients with atrial high rate episodes (AHRE) is going to be terminated prematurely. The reason for early termination is an observed trend towards futility for efficacy...

Almost a year after a SARS-CoV-2 infection, more than half of the participants in a Frankfurt study reported heart problems, such as tachycardia, chest pain and exercise intolerance: that is, symptoms worsening after even minor exertion. A team led by Dr Valentina Puntmann and...

A pill containing aspirin and medications to lower lipids and blood pressure more effectively prevents further adverse cardiovascular events after a heart attack compared with taking the drugs separately. That's the finding of the Europe-wide SECURE study, which has now been...

Atrial fibrillation is recognised and treated more than twice as often in older people using conventional smartphones compared to routine examinations. This is shown by a study presented at this year's European Society of Cardiology (ESC) Congress in Barcelona and published in...